SEB Asset Management AB »

Biosante Pharmaceuticals shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.9M 38k 76.90

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Vanguard Capital Management
Soleus Capital Management
State Street Corporation
Tang Capital Management
Deep Track Capital
Millennium Management
Dimensional Fund Advisors
UBS Group
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Nuveen
Vanguard Portfolio Management
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals